ECHA Board of Appeal | 1 September 2021 | SCAS Europe S.A./N.V., Belgium

Subject matter : A decision taken by the European Chemicals Agency pursuant to Article 46(1) of the REACH Regulation

Remedy sought by the Appellant : By the Contested Decision, the Agency required the registrants of resorcinol to submit information on a larval amphibian growth and development assay (‘LAGDA’) according to OECD test guideline 241.

A first substance evaluation of resorcinol took place in 2017. At that time, the evaluating Member State competent authority considered that performing a LAGDA would not provide relevant new information on the endocrine disrupting properties of resorcinol. The Contested Decision was adopted following a second substance evaluation of resorcinol conducted by another evaluating Member State competent authority.

CONTINUE READING ON: echa.europa.eu